Azacitidine in outpatient treatment – single center experience

AIM OF THE STUDY: Azacitidine is a hypomethylating agent which is used in the treatment of myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia. Because of good tolerance to the drug, azacitidine can be administered both during hospitalization and in an outpatient se...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Contemp Oncol (Pozn)
Päätekijät: Rybka, Justyna, Stefanko, Ewa, Bogucka-Fedorczuk, Aleksandra, Butrym, Aleksandra, Poręba, Rafał, Kuliczkowski, Kazimierz, Wróbel, Tomasz
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Termedia Publishing House 2016
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731453/
https://ncbi.nlm.nih.gov/pubmed/26843844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2015.56653
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia